Dose Assessment of Cefquinome by Pharmacokinetic/Pharmacodynamic Modeling in Mouse Model of Staphylococcus aureus Mastitis

Dose Assessment of Cefquinome by Pharmacokinetic/Pharmacodynamic Modeling in Mouse Model of Staphylococcus aureus Mastitis

This work aimed to characterize the mammary gland pharmacokinetics of cefquinome after an intramammary administration and integrate pharmacokinetic/pharmacodynamic model. The pharmacokinetic profiles of cefquinome in gland tissue were measured using high performance liquid chromatograph. Therapeutic...

Full description

Bibliographic Details
Main Authors:	Yang Yu, Yu-feng Zhou, Xiao Li, Mei-Ren Chen, Gui-Lin Qiao, Jian Sun, Xiaoping Liao, Ya-Hong Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-10-01
Series:	Frontiers in Microbiology
Subjects:	Mastitis Monte Carlo simulation PK/PD modeling Dose assessment Cefquinome
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fmicb.2016.01595/full

Similar Items

Ex Vivo Pharmacokinetics and Pharmacodynamics Modeling and Optimal Regimens Evaluation of Cefquinome Against Bovine Mastitis Caused by Staphylococcus aureus
by: Li-jie Jiang, et al.
Published: (2022-03-01)

Efficacy of Cefquinome against Escherichia coli Environmental Mastitis Assessed by Pharmacokinetic and Pharmacodynamic Integration in Lactating Mouse Model
by: Yang Yu, et al.
Published: (2017-08-01)

Pharmacokinetic/Pharmacodynamic Correlation of Cefquinome against Experimental Catheter-associated Biofilm Infection due to Staphylococcus aureus
by: Yu-Feng eZhou, et al.
Published: (2016-01-01)

Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle
by: Ijaz eAhmad, et al.
Published: (2015-06-01)

Correlation of PK/PD Indices with Resistance Selection for Cefquinome against Staphylococcus aureus in an in vitro Model
by: Yafei eLi, et al.
Published: (2016-04-01)

Murine Thigh Microdialysis to Evaluate the Pharmacokinetic/Pharmacodynamic Integration of Cefquinome Against Actinobacillus pleuropneumoniae
by: Longfei Zhang, et al.
Published: (2020-08-01)

Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome against Streptococcus equi subsp. equi in foals
by: Dong-Ha Lee, et al.
Published: (2020-10-01)

PK/PD Modeling to Assess Rifaximin Clinical Dosage in a Mouse Model of Staphylococcus aureus-Induced Mastitis
by: Honglei Wang, et al.
Published: (2021-06-01)

Pharmacokinetics, bioavailability and dose assessment of Cefquinome against Escherichia coli in black swans (Cygnus atratus)
by: Dong-Hao Zhao, et al.
Published: (2017-07-01)

PK-PD integration of enrofloxacin and cefquinome alone and in combination against Klebsiella pneumoniae using an in vitro dynamic model
by: Yanzhe Wei, et al.
Published: (2023-10-01)

Lung microdialysis and in vivo PK/PD integration of cefquinome against Actinobacillus pleuropneumoniae in a porcine experimental lung infection model
by: Yuqin Chen, et al.
Published: (2024-03-01)

A PK/PD model for the evaluation of clinical rifaximin dosage for the treatment of dairy cow mastitis induced by Escherichia coli
by: Honglei Wang, et al.
Published: (2023-01-01)

Evidence for Establishing the Clinical Breakpoint of Cefquinome against Haemophilus Parasuis in China
by: Kun Mi, et al.
Published: (2021-01-01)

Kill Rate and Evaluation of Ex Vivo PK/PD Integration of Cefquinome Against Actinobacillus pleuropneumoniae
by: Longfei Zhang, et al.
Published: (2021-12-01)

Susceptibility breakpoint for cefquinome against Escherichia coli and Staphylococcus aureus from pigs
by: Hui-lin ZHANG, et al.
Published: (2021-07-01)

In vivo Pharmacokinetic and Pharmacodynamic (PK/PD) Modeling and Establishment of the PK/PD Cutoff of Florfenicol Against Pasteurella multocida in Ducks
by: Xia Xiao, et al.
Published: (2021-01-01)

Microdialysis Determination of Cefquinome Pharmacokinetics in Murine Thigh From Healthy, Neutropenic, and Actinobacillus pleuropneumoniae-Infected Mice
by: Longfei Zhang, et al.
Published: (2019-03-01)

Pharmacokinetic evaluation of cefquinome in febrile goats following intravenous administration
by: RASHMI SAGAR, et al.
Published: (2021-04-01)

In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion.
by: Yang Yu, et al.
Published: (2016-01-01)

Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections?
by: Alicia Rodríguez-Gascón, et al.
Published: (2023-04-01)

Population-Based Pharmacokinetics and Dose Optimization of Imipenem in Vietnamese Critically-Ill Patients
by: Dinh TD, et al.
Published: (2022-08-01)

Environmental fate of cefquinome: Adsorption and degradation
by: Jicheng Qiu, et al.
Published: (2022-10-01)

Pharmacokinetics and Residues of Cefquinome in Milk of Lactating Chinese Dairy Cows After Intramammary Administration
by: Ya-fei LI, et al.
Published: (2014-12-01)

Pharmacokinetic/Pharmacodynamic Based Breakpoints of Polymyxin B for Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Pathogens
by: Xingchen Bian, et al.
Published: (2022-01-01)

Optimizing Antimicrobial Therapy by Integrating Multi-Omics With Pharmacokinetic/Pharmacodynamic Models and Precision Dosing
by: Hui-Yin Yow, et al.
Published: (2022-06-01)

Pharmacokinetic/Pharmacodynamic Modeling of Tulathromycin against Pasteurella multocida in a Porcine Tissue Cage Model
by: Qiaoyi Zhou, et al.
Published: (2017-06-01)

Pharmacokinetic–pharmacodynamic cutoff values for benzylpenicillin in horses to support the establishment of clinical breakpoints for benzylpenicillin antimicrobial susceptibility testing in horses
by: Elodie A. Lallemand, et al.
Published: (2023-10-01)

Histidine Metabolism and IGPD Play a Key Role in Cefquinome Inhibiting Biofilm Formation of Staphylococcus xylosus
by: Yong-hui Zhou, et al.
Published: (2018-04-01)

Pharmacokinetic Behaviour of Enrofloxacin after Single Intramuscular Dosage in American Black Vultures (<i>Coragyps atratus</i>)
by: Samanta Waxman, et al.
Published: (2021-08-01)

Model-Informed Drug Development of New Cefoperazone Sodium and Sulbactam Sodium Combination (3:1): Pharmacokinetic/Pharmacodynamic Analysis and Antibacterial Efficacy Against Enterobacteriaceae
by: Xi-Wei Ji, et al.
Published: (2022-07-01)

Ameliorative Effect of L-Carnitine against Hematological and Hepatorenal Alterations Induced by Cefquinome Sulfate in Male Albino Rats
by: Abd El-Salam F. El-Sawy, et al.
Published: (2023-06-01)

Disposition of Cefquinome in Turkeys (<i>Meleagris gallopavo</i>) Following Intravenous and Intramuscular Administration
by: Mohamed Elbadawy, et al.
Published: (2021-10-01)

Pharmacokinetics and relative bioavailability study of two cefquinome sulfate intramammary infusions in cow milk
by: Shuang Li, et al.
Published: (2024-03-01)

Determination of Susceptibility Breakpoint for Cefquinome against <i>Streptococcus suis</i> in Pigs
by: Kun Mi, et al.
Published: (2021-08-01)

Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant <i>Staphylococcus aureus</i>
by: Katharina Rox, et al.
Published: (2022-12-01)

Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis
by: Xin-Yi Wei, et al.
Published: (2024-04-01)

Pharmacokinetic/pharmacodynamic profiles of baicalin against Mycoplasma gallisepticum in an in vivo infection model
by: Jiaxin Bao, et al.
Published: (2021-11-01)

Dose optimisation based on pharmacokinetic/pharmacodynamic target of tigecycline
by: Bing Leng, et al.
Published: (2021-06-01)

Pharmacokinetic–Pharmacodynamic Modeling of Midazolam in Pediatric Surgery
by: Carmen Flores-Pérez, et al.
Published: (2023-11-01)

The dose regimen formulation of doxycycline hydrochloride and florfenicol injection based on ex vivo pharmacokinetic-pharmacodynamic modeling against the Actinobacillus pleuropneumoniae in pigs
by: Yuanyuan Yuan, et al.
Published: (2023-02-01)